Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
12/06/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/06/202409:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202409:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202407:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202419:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
10/06/202419:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
10/06/202418:27RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202408:39Alliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
10/06/202408:39Alliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
10/06/202407:00RNS Regulatory NewsGSK PLC FDA approves Arexvy for adults 50-59 at riskLSE:GSKGsk Plc
03/06/202415:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
03/06/202414:01Alliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
03/06/202414:01Alliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
03/06/202413:03RNS Regulatory NewsGSK PLC Unprecedented results in Jemperli trial continueLSE:GSKGsk Plc
03/06/202409:08Alliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
03/06/202409:08Alliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
03/06/202407:05RNS Regulatory NewsGSK PLC ASCO positive Blenrep DREAMM-8 trial resultsLSE:GSKGsk Plc
03/06/202407:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
24/05/202408:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
24/05/202408:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
24/05/202407:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
21/05/202408:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202408:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202407:00RNS Regulatory NewsGSK PLC Positive phase III asthma results for depemokimabLSE:GSKGsk Plc
20/05/202416:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
20/05/202416:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
20/05/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
17/05/202409:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202409:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202407:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK